Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07466589 · ClinicalTrials.gov registry record · NA
Advancement of Vestibular Intervention Via Portable Electrical Stimulator (VIPES)
A NA study of Mild Traumatic Brain Injury, Concussion, sponsored by Vivonics.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT07466589: Recruiting NA study of Mild Traumatic Brain Injury, Concussion, sponsored by Vivonics.
NCT07466589 is a NA study of Mild Traumatic Brain Injury, Concussion that is actively recruiting participants, run by Vivonics. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07466589, a NA study of Mild Traumatic Brain Injury, Concussion, is actively recruiting participants, sponsored by Vivonics.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal is to assess the potential benefit of stochastic galvanic vestibular stimulation (sGVS) in improving patient performance with respect to balance, gait, and/or overall vestibular function for individuals with known deficits in vestibular performance as a result of a mild traumatic brain injury (mTBI).
Primary Outcome
Comparison of sway area (deg/s) during mCTSIB at stimulation conditions (0.33mA, 0.67mA, and 1mA) in comparison to randomized Sham (0mA).
Conditions Studied
Interventions
- DEVICE Stochastic Galvanic Vestibular Stimulation (sGVS)
Study Locations (1)
Michigan
- University of Michigan, Michigan Medicine - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-08-22 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT07466589 shows while recruiting
NCT07466589 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Mild Traumatic Brain Injury, Concussion appearing as the primary indexed condition, and to 1 intervention - of which Stochastic Galvanic Vestibular Stimulation (sGVS) is the first listed.
NCT07466589 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07466589 about?
NCT07466589 is a clinical study titled "Advancement of Vestibular Intervention Via Portable Electrical Stimulator (VIPES)". The goal is to assess the potential benefit of stochastic galvanic vestibular stimulation (sGVS) in improving patient performance with respect to balance, gait, and/or overall vestibular function for individuals with known deficits in vestibular performance as a result of a mild traumatic brain inju...
What is the current status of trial NCT07466589?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-08-22. Estimated completion is 2026-03.
What conditions does trial NCT07466589 study?
This clinical trial studies the following conditions: Mild Traumatic Brain Injury, Concussion.
What interventions are being tested in trial NCT07466589?
The interventions under investigation include: Stochastic Galvanic Vestibular Stimulation (sGVS) (DEVICE).
Who is sponsoring clinical trial NCT07466589?
This trial is sponsored by Vivonics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07466589 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Traumatic Brain Injury, Concussion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07466589's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI